search
Back to results

COVID-19 Project ECHO in Nursing Homes

Primary Purpose

Covid19

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Project ECHO
Sponsored by
Milton S. Hershey Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Covid19 focused on measuring Project ECHO, telehealth

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria for Facilities Skilled Nursing Facility in United States Access to computer or electronic device

Exclusion Criteria for Facilities Previously participated in Project ECHO COVID-19 series either through Penn State or another institution

Sites / Locations

  • Penn State College of Medicine, Penn State Milton S. Hershey Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

ECHO plus

ECHO

Arm Description

Nursing homes in this arm will receive the intervention via real-time, interactive videoconferencing using Zoom at no cost to participants. Sessions will be 90 minutes in duration and held weekly for 6 months (25 sessions total) at regularly scheduled times. Participants in this arm will receive a 2 month (8 sessions total) refresher course in Fall 2021. Project ECHO utilizes case-based, collaborative learning to support discussion of learners' challenges and barriers to guideline implementation

Nursing homes in this arm will receive the intervention via real-time, interactive videoconferencing using Zoom at no cost to participants. Sessions will be 90 minutes in duration and held weekly for 6 months (25 sessions total) at regularly scheduled times. Project ECHO utilizes case-based, collaborative learning to support discussion of learners' challenges and barriers to guideline implementation

Outcomes

Primary Outcome Measures

Infection rate
Rate of COVID-19 infection in enrolled nursing homes

Secondary Outcome Measures

Hospitalization
Number of COVID-19 hospitalizations from enrolled nursing homes
Death
Number of COVID-19 deaths from enrolled nursing homes
Flu-like illness
Number of flu-like illnesses reported from enrolled nursing homes

Full Information

First Posted
July 31, 2020
Last Updated
September 20, 2022
Sponsor
Milton S. Hershey Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04499391
Brief Title
COVID-19 Project ECHO in Nursing Homes
Official Title
COVID-19 Project ECHO for Nursing Homes: A Patient-centered, Randomized-controlled Trial to Implement Infection Control and Quality of Life Best Practice
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
December 4, 2020 (Actual)
Primary Completion Date
October 2022 (Anticipated)
Study Completion Date
October 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Milton S. Hershey Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Nursing homes are ground zero for the COVID-19 pandemic. Nursing homes are ill-equipped for the pandemic; though facilities are required to have infection control staff, only 3% have taken a basic infection control course. Significant research has focused on infection control in the acute care setting. However, little is known about the implementation of practices and effective interventions in long-term care facilities.The investigators propose an intervention utilizing Project ECHO, an evidence-based telehealth model, to connect Penn State University experts with remote nursing home staff and administrators to proactively support evidence-based infection control guideline implementation. Our study seeks to answer the critical research question of how evidence-based infection control guidelines can be implemented effectively in nursing homes
Detailed Description
The investigators will recruit 200 nursing homes with approximately 24,560 residents from across the United States through collaborations with our stakeholders. Nursing homes will be randomized to one of two arms: 1) AHRQ-funded COVID-19 ECHO that includes 16 weekly telehealth sessions addressing COVID-19 guidelines and best practices or 2) AHRQ-funded COVID-19 ECHO plus an additional 9 sessions with a focus on CDC infection control training. Randomization will be stratified by characteristics of nursing homes to ensure balance among the two trial groups, including size (number of beds),geographic location, and current COVID-19 infection rate. Patient-centered outcomes (nursing home residents with COVID-19 infections, hospitalizations, deaths, and QOL) will be assessed at baseline, 4, 6, 12, and 18 months. Our study is guided by the RE-AIM framework to critically evaluate both effectiveness and implementation outcomes of the proposed intervention. The RE-AIM framework is frequently utilized to improve sustainable adoption and implementation of effective, generalizable, evidence-based interventions like Project ECHO.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Covid19
Keywords
Project ECHO, telehealth

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
stratified cluster randomized design
Masking
None (Open Label)
Allocation
Randomized
Enrollment
136 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
ECHO plus
Arm Type
Experimental
Arm Description
Nursing homes in this arm will receive the intervention via real-time, interactive videoconferencing using Zoom at no cost to participants. Sessions will be 90 minutes in duration and held weekly for 6 months (25 sessions total) at regularly scheduled times. Participants in this arm will receive a 2 month (8 sessions total) refresher course in Fall 2021. Project ECHO utilizes case-based, collaborative learning to support discussion of learners' challenges and barriers to guideline implementation
Arm Title
ECHO
Arm Type
Active Comparator
Arm Description
Nursing homes in this arm will receive the intervention via real-time, interactive videoconferencing using Zoom at no cost to participants. Sessions will be 90 minutes in duration and held weekly for 6 months (25 sessions total) at regularly scheduled times. Project ECHO utilizes case-based, collaborative learning to support discussion of learners' challenges and barriers to guideline implementation
Intervention Type
Other
Intervention Name(s)
Project ECHO
Intervention Description
Project ECHO utilizes case-based, collaborative learning to support discussion of learners' challenges and barriers to guideline implementation. This differentiates ECHO from traditional learning and facilitates rapid dissemination of medical knowledge and increased capacity to deliver best-practice care.studying innovative approaches.
Primary Outcome Measure Information:
Title
Infection rate
Description
Rate of COVID-19 infection in enrolled nursing homes
Time Frame
Baseline, 4, 6, 12, 18 months
Secondary Outcome Measure Information:
Title
Hospitalization
Description
Number of COVID-19 hospitalizations from enrolled nursing homes
Time Frame
Baseline, 4, 6, 12, 18 months
Title
Death
Description
Number of COVID-19 deaths from enrolled nursing homes
Time Frame
Baseline, 4, 6, 12, 18 months
Title
Flu-like illness
Description
Number of flu-like illnesses reported from enrolled nursing homes
Time Frame
Baseline, 4, 6, 12, 18 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria for Facilities Skilled Nursing Facility in United States Access to computer or electronic device Exclusion Criteria for Facilities Previously participated in Project ECHO COVID-19 series either through Penn State or another institution
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jennifer Kraschnewski
Phone
717-531-7778
Email
jkraschnewski@pennstatehealth.psu.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Erica Francis
Email
efrancis@psu.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer Kraschnewski
Organizational Affiliation
Penn State College of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
City
Hershey
State/Province
Pennsylvania
ZIP/Postal Code
17033
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer L Kraschnewski, MD, MPH
Phone
717-531-0003
Ext
283891
Email
jkraschnewski@hmc.psu.edu
First Name & Middle Initial & Last Name & Degree
Jennifer L Kraschnewski, MD, MPH

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35476823
Citation
Calo WA, Francis E, Kong L, Hogentogler R, Heilbrunn E, Fisher A, Hood N, Kraschnewski J. Implementing Infection Control and Quality of Life Best Practices in Nursing Homes With Project ECHO: Protocol for a Patient-Centered Randomized Controlled Trial. JMIR Res Protoc. 2022 May 13;11(5):e34480. doi: 10.2196/34480.
Results Reference
derived

Learn more about this trial

COVID-19 Project ECHO in Nursing Homes

We'll reach out to this number within 24 hrs